ES8505545A1 - Un procedimiento para producir un preparado de gamma-interferon estable - Google Patents
Un procedimiento para producir un preparado de gamma-interferon estableInfo
- Publication number
- ES8505545A1 ES8505545A1 ES534815A ES534815A ES8505545A1 ES 8505545 A1 ES8505545 A1 ES 8505545A1 ES 534815 A ES534815 A ES 534815A ES 534815 A ES534815 A ES 534815A ES 8505545 A1 ES8505545 A1 ES 8505545A1
- Authority
- ES
- Spain
- Prior art keywords
- gamma interferon
- interferon composition
- composition
- lyophilizing
- xylitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCEDIMIENTO PARA LA PRODUCCION DE UN PREPARADO DE GAMMA-INTERFERON ESTABLE.CONSISTE EN AN/ADIR A UNA SOLUCION ACUOSA QUE CONTIENE ENTRE 1D10 Y 1D10 UNIDADES DE UN GAMMA-INTERFERON DE ORIGEN DE LEUCOCITOS HUMANOS, AL MENOS 5 MG DE UN AZUCAR O AL MENOS 3 MG DE ALBUMINA DE SUERO HUMANO, Y EN LIOFILIZAR LA SOLUCION A UN PH COMPRENDIDO ENTRE 5 Y 9. EL AZUCAR UTILIZADO PUEDE SER UN MONOSACARIDO, UN DISACARIDO O UN AZUCAR-ALCOHOL.DE APLICACION EN MEDICINA Y FARMACIA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14348483A JPS6034919A (ja) | 1983-08-04 | 1983-08-04 | ガンマ・インタ−フェロン組成物 |
JP58157560A JPH0651641B2 (ja) | 1983-08-29 | 1983-08-29 | ガンマ・インターフェロン組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES534815A0 ES534815A0 (es) | 1985-06-01 |
ES8505545A1 true ES8505545A1 (es) | 1985-06-01 |
Family
ID=26475198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES534815A Expired ES8505545A1 (es) | 1983-08-04 | 1984-08-02 | Un procedimiento para producir un preparado de gamma-interferon estable |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0133767B1 (es) |
CA (1) | CA1223207A (es) |
DE (1) | DE3484374D1 (es) |
ES (1) | ES8505545A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702699A (en) * | 1982-09-23 | 1997-12-30 | Cetus Corporation | Process for the recovery of lipophilic proteins |
US5643566A (en) * | 1982-09-23 | 1997-07-01 | Cetus Corporation | Formulation processes for lipophilic proteins |
US4797388A (en) * | 1984-05-21 | 1989-01-10 | Cetus Corporation | Pharmaceutical compositions with galactitol as carrier |
MA20647A1 (fr) * | 1985-03-25 | 1986-10-01 | Schering Corp | Compositions stables a base d'interferon-gamma |
GB8522336D0 (en) * | 1985-09-09 | 1985-10-16 | Biogen Nv | Composition for treatment of allergies |
US4933433A (en) * | 1986-01-31 | 1990-06-12 | E. I. Du Pont De Nemours And Company | Recombinant interleukin-2 composition and process for making it |
US5183746A (en) * | 1986-10-27 | 1993-02-02 | Schering Aktiengesellschaft | Formulation processes for pharmaceutical compositions of recombinant β- |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
US4895716A (en) * | 1987-06-09 | 1990-01-23 | Biogen, Inc. | Stabilized formulations of gamma interferons |
US5151265A (en) * | 1987-11-03 | 1992-09-29 | Genentech, Inc. | Gamma interferon formulation |
US5004605A (en) * | 1987-12-10 | 1991-04-02 | Cetus Corporation | Low pH pharmaceutical compositions of recombinant β-interferon |
IT1216056B (it) * | 1988-03-11 | 1990-02-22 | Sclavo Spa | Composizioni farmaceutiche contenenti timosina alfa 1. |
US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
CA2024046A1 (en) * | 1989-09-28 | 1991-03-29 | Alberto Ferro | Stabilized leukocyte-interferons |
LT3987B (en) | 1992-02-17 | 1996-06-25 | Fermentas Biotech Inst | Stabilized interferon compositions |
EP0920329B1 (en) * | 1996-05-09 | 2002-09-25 | Feronpatent Limited | Stabilization of interferons in aqueous solution by arabic gum |
AU730020B2 (en) * | 1997-05-09 | 2001-02-22 | Feronpatent Limited | Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
AU740735B2 (en) * | 1997-08-01 | 2001-11-15 | Toray Industries, Inc. | Method for stabilizing useful proteins and useful protein compositions |
PT1343518E (pt) | 2000-11-07 | 2009-08-03 | Novartis Vaccines & Diagnostic | Composições de interferão estabilizadas |
US6887462B2 (en) | 2001-04-09 | 2005-05-03 | Chiron Corporation | HSA-free formulations of interferon-beta |
EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU561343B2 (en) * | 1981-10-19 | 1987-05-07 | Genentech Inc. | Human immune interferon by recombinant dna |
DE3273597D1 (en) * | 1981-11-28 | 1986-11-06 | Sunstar Kk | Pharmaceutical composition containing interferon in stable state |
ZA83768B (en) * | 1982-03-01 | 1983-10-26 | Hoffmann La Roche | Homogeneous human immune interferon and process therefor |
WO1984002129A1 (en) * | 1982-11-22 | 1984-06-07 | Takeda Chemical Industries Ltd | Human immune interferon protein and process for its preparation |
-
1984
- 1984-07-23 DE DE8484304992T patent/DE3484374D1/de not_active Expired - Lifetime
- 1984-07-23 EP EP19840304992 patent/EP0133767B1/en not_active Expired
- 1984-07-30 CA CA000459960A patent/CA1223207A/en not_active Expired
- 1984-08-02 ES ES534815A patent/ES8505545A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES534815A0 (es) | 1985-06-01 |
EP0133767B1 (en) | 1991-04-03 |
DE3484374D1 (de) | 1991-05-08 |
EP0133767A3 (en) | 1986-12-17 |
CA1223207A (en) | 1987-06-23 |
EP0133767A2 (en) | 1985-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8505545A1 (es) | Un procedimiento para producir un preparado de gamma-interferon estable | |
Nutton | From Galen to Alexander, aspects of medicine and medical practice in late antiquity | |
DE3868037D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
UA26303A1 (uk) | Фармацевтичhа композиція, яка має імуhосупресорhу та аhтимікробhу активhість | |
AU2789989A (en) | Acylated uridine and cytidine and uses thereof | |
IE38825B1 (en) | Stable viral preparations | |
ES2010226A6 (es) | Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos | |
UA26855C2 (uk) | Фармацевтичhа композиція, яка регулює гематопоез | |
ES8706446A1 (es) | Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores. | |
CA2151732A1 (en) | Stable lyophilized pharmaceutical preparations of g-csf | |
HUT74270A (en) | Aqueous pharmaceutical preparations of g-csf with a long shelf life and process to prepare them | |
JPS57140724A (en) | Heat-treatment of aqueous solution containing cold insoluble globulin | |
AU6319896A (en) | Lyophilized hgf preparations | |
IL90551A (en) | Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions | |
IE831462L (en) | Pharmaceutical preparations containing release controlling¹substance. | |
GB1044649A (en) | Improvements in or relating to the preservation of blood | |
SE8700137L (sv) | Diuretisk komposition | |
EP0259982A3 (en) | Solid iodophor composition | |
ATE101049T1 (de) | Transdermales arzneimittel. | |
AU1076388A (en) | High level expression in e. coli of soluble mature hil-beta and derivatives with altered biological activity | |
EP0240274A3 (en) | Avermectins as growth promotant agents | |
IT8848243A0 (it) | Il disturbo provocato da insetti metodo e composizione per evitare succhiatori di sangue | |
IE38514L (en) | Insulin preparations. | |
ES2044091T3 (es) | Formulaciones anti-neoplasticas. | |
EP0310410A3 (en) | Control of calcium activated potassium efflux from injured body cells |